These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 19808324

  • 21. Utility of cystatin C as a marker for the severity of aortic regurgitation in hypertensive patients.
    Iida M, Yamamoto M, Ishiguro YS, Yamazaki M, Ueda N, Honjo H, Kamiya K.
    Clin Chim Acta; 2013 Oct 21; 425():259-64. PubMed ID: 23954770
    [Abstract] [Full Text] [Related]

  • 22. Left ventricular hypertrophy, aortic wall thickness, and lifetime predicted risk of cardiovascular disease:the Dallas Heart Study.
    Gupta S, Berry JD, Ayers CR, Peshock RM, Khera A, de Lemos JA, Patel PC, Markham DW, Drazner MH.
    JACC Cardiovasc Imaging; 2010 Jun 21; 3(6):605-13. PubMed ID: 20541716
    [Abstract] [Full Text] [Related]

  • 23. Cystatin C and Cardiac Measures in Children and Adolescents With CKD.
    Brady TM, Townsend K, Schneider MF, Cox C, Kimball T, Madueme P, Warady B, Furth S, Mitsnefes M.
    Am J Kidney Dis; 2017 Feb 21; 69(2):247-256. PubMed ID: 27856090
    [Abstract] [Full Text] [Related]

  • 24. Cystatin C: A Promising Marker of Renal Function in Patients with Systemic Lupus Erythematosus?
    Peixoto L, Aguiar P, de Bragança R, Martins JR, Acabado AJ, Ducla-Sores JL.
    Acta Med Port; 2015 Feb 21; 28(3):333-41. PubMed ID: 26421786
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Changes in left ventricular mass and volumes in patients receiving angiotensin-converting enzyme inhibitor therapy for left ventricular dysfunction after Q-wave myocardial infarction.
    Foster RE, Johnson DB, Barilla F, Blackwell GG, Orr R, Roney M, Stanley AW, Pohost GM, Dell'Italia LJ.
    Am Heart J; 1998 Aug 21; 136(2):269-75. PubMed ID: 9704689
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Left Ventricular Structure and Risk of Cardiovascular Events: A Framingham Heart Study Cardiac Magnetic Resonance Study.
    Tsao CW, Gona PN, Salton CJ, Chuang ML, Levy D, Manning WJ, O'Donnell CJ.
    J Am Heart Assoc; 2015 Sep 15; 4(9):e002188. PubMed ID: 26374295
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Dynamic Relation of Changes in Weight and Indices of Fat Distribution With Cardiac Structure and Function: The Dallas Heart Study.
    Wilner B, Garg S, Ayers CR, Maroules CD, McColl R, Matulevicius SA, de Lemos JA, Drazner MH, Peshock R, Neeland IJ.
    J Am Heart Assoc; 2017 Jul 19; 6(7):. PubMed ID: 28724650
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.